Brainsway Ltd.

8.96-0.0200-0.22%Vol 13.54K1Y Perf 52.28%
Jul 30th, 2021 15:59 DELAYED
BID8.95 ASK9.00
Open8.87 Previous Close8.98
Pre-Market- After-Market-
 - -  - -%
Target Price
14.90 
Analyst Rating
Strong Buy 1.33
Potential %
66.29 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     60.90
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     55.98
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap147.39M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
54.82 
Earnings Date
11th Aug 2021

Today's Price Range

8.879.01

52W Range

5.5511.77

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-0.78%
1 Month
-12.16%
3 Months
3.94%
6 Months
12.70%
1 Year
52.28%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BWAY8.96-0.0200-0.22
AAPL145.860.22000.15
GOOG2 704.42-26.3900-0.97
MSFT284.91-1.5900-0.55
XOM57.57-1.3600-2.31
WFC45.94-0.5600-1.20
JNJ172.200.02000.01
FB356.30-2.0200-0.56
GE12.95-0.3400-2.56
JPM151.78-1.2200-0.80
Financial StrengthValueIndustryS&P 500US Markets
9.70
9.70
-
0.02
-17.40
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
76.90
-15.10
-4.10
-35.70
-21.35
RevenueValueIndustryS&P 500US Markets
19.20M
1.17
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.08-0.11-37.50
Q04 2020-0.05-0.0260.00
Q03 2020-0.06-0.0433.33
Q02 2020-0.12-0.0375.00
Q01 2020-0.16-0.156.25
Q04 2019-0.12-0.1016.67
Q03 2019-0.13-0.127.69
Q02 2019-0.11-0.17-54.55
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.06-20.00Negative
9/2021 QR-0.050.00-
12/2021 FY-0.27-22.73Negative
12/2022 FY-0.16-33.33Negative
Next Report Date11th Aug 2021
Estimated EPS Next Report-0.06
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume13.54K
Shares Outstanding16.45M
Trades Count86
Dollar Volume1.70M
Avg. Volume65.70K
Avg. Weekly Volume29.47K
Avg. Monthly Volume30.16K
Avg. Quarterly Volume41.24K

Brainsway Ltd. (NASDAQ: BWAY) stock closed at 8.96 per share at the end of the most recent trading day (a -0.22% change compared to the prior day closing price) with a volume of 13.54K shares and market capitalization of 147.39M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 107 people. Brainsway Ltd. CEO is Christopher Richard von Jako.

The one-year performance of Brainsway Ltd. stock is 52.28%, while year-to-date (YTD) performance is 18.83%. BWAY stock has a five-year performance of %. Its 52-week range is between 5.55 and 11.77, which gives BWAY stock a 52-week price range ratio of 54.82%

Brainsway Ltd. currently has a PE ratio of -22.30, a price-to-book (PB) ratio of 2.39, a price-to-sale (PS) ratio of 7.74, a price to cashflow ratio of 123.50, a PEG ratio of 2.32, a ROA of -8.41%, a ROC of -11.34% and a ROE of -11.34%. The company’s profit margin is -21.35%, its EBITDA margin is -4.10%, and its revenue ttm is $19.20 Million , which makes it $1.17 revenue per share.

Of the last four earnings reports from Brainsway Ltd., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Brainsway Ltd.’s next earnings report date is 11th Aug 2021.

The consensus rating of Wall Street analysts for Brainsway Ltd. is Strong Buy (1.33), with a target price of $14.9, which is +66.29% compared to the current price. The earnings rating for Brainsway Ltd. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Brainsway Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Brainsway Ltd. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.99, ATR14 : 0.29, CCI20 : -66.06, Chaikin Money Flow : -0.38, MACD : -0.34, Money Flow Index : 19.32, ROC : -4.07, RSI : 35.42, STOCH (14,3) : 31.63, STOCH RSI : 0.95, UO : 33.05, Williams %R : -68.37), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Brainsway Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
3 (75.00 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.25

Brainsway Ltd.

Brainsway Ltd is an Israel based company engaged in the business of developing and providing advanced technology solutions for the treatment of a variety of brain disorders. Its flagship technology is based on Deep Transcranial Magnetic Stimulation (TMS) which is used for brain disorder treatment such as treatment of depression in patients. The group earns revenues from the sale and lease of devices. It has a business presence in Israel and other foreign countries.

CEO: Christopher Richard von Jako

Telephone: +972 25813140

Address: 19 Hartum Street, Jerusalem 9777518, , IL

Number of employees: 107

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

67%33%

Bearish Bullish

77%23%

News

Stocktwits